AFP and hepatocellular carcinoma: Because of this, various biomarkers such as des-gamma-carboxy prothrombin (DCP) and AFP Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) have been developed and reported to be clinically useful (7, 8), however a prognostic marker with the ability to predict HCC patient survival has not been discovered.